<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02198573</url>
  </required_header>
  <id_info>
    <org_study_id>WHO_3DF_2013_day3</org_study_id>
    <nct_id>NCT02198573</nct_id>
  </id_info>
  <brief_title>Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar</brief_title>
  <official_title>Molecular Assessment of Artemisinin Resistance Markers, K13 Kelch Propeller and Multi-drug Resistant Gene Polymorphism in Eastern and Western Border Areas of Myanmar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Myat Htut Nyunt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kangwon National University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Department of Medical Research, Lower Myanmar</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Artemisinin resistance have been documented in Myanmar and Myanmar artemisinin
           resistance containment measures have been launched since 2009-2010.

        -  It is important to monitor the spread and magnitude of artemisinin resistant malaria in
           Myanmar.

        -  So, day-3 surveillance study have been conducted.

        -  Recently artemisinin resistant molecular marker, K13 have been identified and it was
           used as a tool in this study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>day-3 parasite positivity</measure>
    <time_frame>3 days</time_frame>
    <description>All of the enrolled patients were monitored with appropriate care up to third day and take the samples on day-3.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of the drug resistance marker</measure>
    <time_frame>up to day-3</time_frame>
    <description>By using the dried blood spots, drug resistance markers were detected by molecular method.</description>
  </secondary_outcome>
  <enrollment type="Actual">91</enrollment>
  <condition>Day-3 Positive of Parasitaemia</condition>
  <condition>Prevalence of Drug Resistance Gene Mutation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      dried blood spot
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All of the malaria suspected cases were invited to participated in this study from
        Myanmar-Thailand border and Myanmar-Bangladesh border.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed uncomplicated falciparum malaria patients.

          -  age &gt;2 years

          -  box sex

          -  given informed consent

        Exclusion Criteria:

          -  severe malaria

          -  did not give informed consent

          -  others diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myat P Kyaw, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Medical Research, Lower Myanmar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Myat Phone Kyaw</name>
      <address>
        <city>Yangon</city>
        <zip>11191</zip>
        <country>Myanmar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Myanmar</country>
  </location_countries>
  <reference>
    <citation>World Health Organization. World Malaria Report 2013. Geneva, Switzerland, 2013.</citation>
  </reference>
  <reference>
    <citation>World Health Organization. Global report on antimalarial efficacy and drug resistance: 2000-2010. Geneva, Switzerland: World Health Organization, 2010.</citation>
  </reference>
  <reference>
    <citation>Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010 Feb 15;201(4):570-9. doi: 10.1086/650301.</citation>
    <PMID>20085495</PMID>
  </reference>
  <reference>
    <citation>Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.</citation>
    <PMID>24352242</PMID>
  </reference>
  <reference>
    <citation>Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999 Apr;60(4):687-92.</citation>
    <PMID>10348249</PMID>
  </reference>
  <results_reference>
    <citation>Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, Lindegardh N, Tarning J, Imwong M, Jacob CG, Rasmussen C, Perin J, Ringwald P, Nyunt MM. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One. 2013;8(3):e57689. doi: 10.1371/journal.pone.0057689. Epub 2013 Mar 8.</citation>
    <PMID>23520478</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2014</study_first_submitted>
  <study_first_submitted_qc>July 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2014</study_first_posted>
  <last_update_submitted>July 22, 2014</last_update_submitted>
  <last_update_submitted_qc>July 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Department of Medical Research, Lower Myanmar</investigator_affiliation>
    <investigator_full_name>Myat Htut Nyunt</investigator_full_name>
    <investigator_title>Dr. Myat Htut Nyunt</investigator_title>
  </responsible_party>
  <keyword>malaria</keyword>
  <keyword>K13</keyword>
  <keyword>pfmrp1</keyword>
  <keyword>Myanmar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parasitemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Artemisinins</mesh_term>
    <mesh_term>Artemisinine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

